Abstract:BackgroundAlzheimer’s disease (AD) and vascular contributions to cognitive impairment and dementia (VCID) pathologies coexist in patients with cognitive impairment. Abnormal amyloid beta (Aβ) deposition is the hallmark pathologic biomarker for AD. Neuroinflammation may be a pathophysiological mechanism in both AD and VCID. In this study, we aimed to understand the role of neuroinflammation and Aβ deposition in white matter hyperintensities (WMH) progression and cognitive decline over a decade in patients with mixed AD and VCID pathologies.MethodsTwenty-four elderly participants (median [interquartile range] age 78 [64.8, 83] years old, 14 female) were recruited from the Knight Alzheimer Disease Research Center. 11C-PK11195 standard uptake value ratio (SUVR) and 11C-PiB mean cortical binding potential (MCBP) were used to evaluate neuroinflammation and Aβ deposition in-vivo, respectively. Fluid-attenuated inversion recovery MR images were acquired to obtain baseline WMH volume and its progression over 11.5 years. Composite cognitive scores (global, processing speed and memory) were computed at baseline and follow-up over 7.5 years. Multiple linear regression models evaluated the association between PET biomarkers (11C-PK11195 SUVR and 11C-PiB MCBP) and baseline WMH volume and cognitive function. Moreover, linear mixed-effects models evaluated whether PET biomarkers predicted greater WMH progression or cognitive decline over a decade.ResultsFifteen participants (62.5%) had mixed AD (positive PiB) and VCID (at least one vascular risk factor) pathologies. Elevated 11C-PK11195 SUVR, but not 11C-PiB MCBP, was associated with greater baseline WMH volume and predicted greater WMH progression. Elevated 11C-PiB MCBP was associated with baseline memory and global cognition. Elevated 11C-PK11195 SUVR and elevated 11C-PiB MCBP independently predicted greater global cognition and processing speed declines. No association was found between 11C-PK11195 SUVR and 11C-PiB MCBP.ConclusionsNeuroinflammation and Aβ deposition may represent two distinct pathophysiological pathways, and both independently contributed to the progression of cognitive impairment in mixed AD and VCID pathologies. Neuroinflammation, but not Aβ deposition, contributed to WMH volume and progression.

Vascular Risk Factors Aggravate the Progression of Alzheimer's Disease

Vascular risk factors aggravate the progression of Alzheimer's disease: a 3-year follow-up study of Chinese population.

Aggregation of Vascular Risk Factors Modulates the Amplitude of Low-Frequency Fluctuation in Mild Cognitive Impairment Patients

The Correlation Between Vascular Risk Factors and Alzheimer's Disease

Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum

Associations Of Vascular Risk With Cognition, Brain Glucose Metabolism, And Clinical Progression In Cognitively Intact Elders

Vascular Risk Factors Promote Conversion from Mild Cognitive Impairment to Alzheimer Disease.

Correlation of Alzheimer’s disease with the risk factors like vascular and metabolic risk factors

Associations Between APOE Genotype and Cerebral Small-Vessel Disease: a Longitudinal Study

Vascular Risk Factors and Brain Health in Aging: Insights from a Community-Based Cohort Study

Midlife Vascular Risk Factors and the Risk of Alzheimer's Disease: a Systematic Review and Meta-Analysis.

Distinct Cerebral Small Vessel Disease Impairment in Early- and Late-Onset Alzheimer's Disease.

Alzheimer's Disease and "the Vascular Hypothesis":Coincidence or Accomplice?

Alzheimer disease and arteriosclerosis and their risk factors

Association Between Serum Vitamins and the Risk of Alzheimer's Disease in Chinese Population

The effect of Alzheimer’s disease risk factors on brain aging in normal Chineses: Cognitive aging and cognitive reserve

Alzheimer's disease pathology: pathways between chronic vascular risk factors and blood-brain barrier dysfunction in a cohort of patients with different types of dementia

Cardiovascular and Other Risk Factors for Alzheimer's Disease and Vascular Dementia

Neuroinflammation and amyloid deposition in the progression of mixed Alzheimer and vascular dementia

Vascular contributions to Alzheimer's disease